The Discovery and Structure‐Activity Evaluation of (+)‐Floyocidin B and Synthetic Analogs

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: Online-Ressource

Language: Englisch

Bibliographic citation: The Discovery and Structure‐Activity Evaluation of (+)‐Floyocidin B and Synthetic Analogs ; day:17 ; month:11 ; year:2021 ; extent:1
ChemMedChem ; (17.11.2021) (gesamt 1)

Creator: Kleiner, Yolanda
Pöverlein, Christoph
Klädtke, Jannike
Kurz, Michael
König, Henrik
Becker, Jonathan
Mihajlovic, Sanja
Zubeil, Florian
Marner, Michael
Vilcinskas, Andreas
Schäberle, Till F.
Hammann, Peter
Schuler, Sören M. M.
Bauer, Armin

DOI: 10.1002/cmdc.202100644

URN: urn:nbn:de:101:1-2021111814030927889900

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:28 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Kleiner, Yolanda
Pöverlein, Christoph
Klädtke, Jannike
Kurz, Michael
König, Henrik
Becker, Jonathan
Mihajlovic, Sanja
Zubeil, Florian
Marner, Michael
Vilcinskas, Andreas
Schäberle, Till F.
Hammann, Peter
Schuler, Sören M. M.
Bauer, Armin

Other Objects (12)

Discovery of antifungal and antibacterial volatile natural products and synthetic drug analogs

Synthesis and Structure‐Activity Relationship Studies of C (13)‐Desmethylene‐(−)‐Zampanolide Analogs

Synthetic optimization of cystobactamid analogs as antibiotics

Hochschulschrift

Synthetic and structure-activity studies of the 20S proteasome inhibitor syringolin A

Hochschulschrift

Synthetic and structure-activity studies of the 20S proteasome inhibitor Syringolin A

Investigation of the structure-activity relationship at the N-terminal part of minigastrin analogs

Cepharanthine analogs mining and genomes of Stephania accelerate anti-coronavirus drug discovery

Screening of the antileishmanial and antiplasmodial potential of synthetic 2-arylquinoline analogs

Novel Synthetic Clot Analogs for In-Vitro Stroke Modelling

Novel synthetic clot analogs for in-vitro stroke modelling

Hochschulschrift

Genetic code engineering with methionine analogs for synthetic biotechnology

Structure–activity characteristics of phenylalanine analogs selectively transported by L-type amino acid transporter 1 (LAT1)

Discovery of antifungal and antibacterial volatile natural products and synthetic drug analogs

Synthesis and Structure‐Activity Relationship Studies of C (13)‐Desmethylene‐(−)‐Zampanolide Analogs

Synthetic optimization of cystobactamid analogs as antibiotics

Hochschulschrift

Synthetic and structure-activity studies of the 20S proteasome inhibitor syringolin A

Hochschulschrift

Synthetic and structure-activity studies of the 20S proteasome inhibitor Syringolin A

Investigation of the structure-activity relationship at the N-terminal part of minigastrin analogs

Cepharanthine analogs mining and genomes of Stephania accelerate anti-coronavirus drug discovery

Screening of the antileishmanial and antiplasmodial potential of synthetic 2-arylquinoline analogs

Novel Synthetic Clot Analogs for In-Vitro Stroke Modelling

Novel synthetic clot analogs for in-vitro stroke modelling

Hochschulschrift

Genetic code engineering with methionine analogs for synthetic biotechnology

Structure–activity characteristics of phenylalanine analogs selectively transported by L-type amino acid transporter 1 (LAT1)

Discovery of antifungal and antibacterial volatile natural products and synthetic drug analogs

Synthesis and Structure‐Activity Relationship Studies of C (13)‐Desmethylene‐(−)‐Zampanolide Analogs

Synthetic optimization of cystobactamid analogs as antibiotics

Hochschulschrift

Synthetic and structure-activity studies of the 20S proteasome inhibitor syringolin A

Hochschulschrift

Synthetic and structure-activity studies of the 20S proteasome inhibitor Syringolin A

Investigation of the structure-activity relationship at the N-terminal part of minigastrin analogs

Cepharanthine analogs mining and genomes of Stephania accelerate anti-coronavirus drug discovery

Screening of the antileishmanial and antiplasmodial potential of synthetic 2-arylquinoline analogs

Novel Synthetic Clot Analogs for In-Vitro Stroke Modelling

Novel synthetic clot analogs for in-vitro stroke modelling

Hochschulschrift

Genetic code engineering with methionine analogs for synthetic biotechnology

Structure–activity characteristics of phenylalanine analogs selectively transported by L-type amino acid transporter 1 (LAT1)

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

The Discovery and Structure‐Activity Evaluation of (+)‐Floyocidin B and Synthetic Analogs

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Discovery of antifungal and antibacterial volatile natural products and synthetic drug analogs

Synthesis and Structure‐Activity Relationship Studies of C (13)‐Desmethylene‐(−)‐Zampanolide Analogs

Synthetic optimization of cystobactamid analogs as antibiotics

Synthetic and structure-activity studies of the 20S proteasome inhibitor syringolin A

Synthetic and structure-activity studies of the 20S proteasome inhibitor Syringolin A

Investigation of the structure-activity relationship at the N-terminal part of minigastrin analogs

Cepharanthine analogs mining and genomes of Stephania accelerate anti-coronavirus drug discovery

Screening of the antileishmanial and antiplasmodial potential of synthetic 2-arylquinoline analogs

Novel Synthetic Clot Analogs for In-Vitro Stroke Modelling

Novel synthetic clot analogs for in-vitro stroke modelling

Genetic code engineering with methionine analogs for synthetic biotechnology

Structure–activity characteristics of phenylalanine analogs selectively transported by L-type amino acid transporter 1 (LAT1)

Discovery of antifungal and antibacterial volatile natural products and synthetic drug analogs

Synthesis and Structure‐Activity Relationship Studies of C (13)‐Desmethylene‐(−)‐Zampanolide Analogs

Synthetic optimization of cystobactamid analogs as antibiotics

Synthetic and structure-activity studies of the 20S proteasome inhibitor syringolin A

Synthetic and structure-activity studies of the 20S proteasome inhibitor Syringolin A

Investigation of the structure-activity relationship at the N-terminal part of minigastrin analogs

Cepharanthine analogs mining and genomes of Stephania accelerate anti-coronavirus drug discovery

Screening of the antileishmanial and antiplasmodial potential of synthetic 2-arylquinoline analogs

Novel Synthetic Clot Analogs for In-Vitro Stroke Modelling

Novel synthetic clot analogs for in-vitro stroke modelling

Genetic code engineering with methionine analogs for synthetic biotechnology

Structure–activity characteristics of phenylalanine analogs selectively transported by L-type amino acid transporter 1 (LAT1)

Discovery of antifungal and antibacterial volatile natural products and synthetic drug analogs

Synthesis and Structure‐Activity Relationship Studies of C (13)‐Desmethylene‐(−)‐Zampanolide Analogs

Synthetic optimization of cystobactamid analogs as antibiotics

Synthetic and structure-activity studies of the 20S proteasome inhibitor syringolin A

Synthetic and structure-activity studies of the 20S proteasome inhibitor Syringolin A

Investigation of the structure-activity relationship at the N-terminal part of minigastrin analogs

Cepharanthine analogs mining and genomes of Stephania accelerate anti-coronavirus drug discovery

Screening of the antileishmanial and antiplasmodial potential of synthetic 2-arylquinoline analogs

Novel Synthetic Clot Analogs for In-Vitro Stroke Modelling

Novel synthetic clot analogs for in-vitro stroke modelling

Genetic code engineering with methionine analogs for synthetic biotechnology

Structure–activity characteristics of phenylalanine analogs selectively transported by L-type amino acid transporter 1 (LAT1)

Related objects

Reset password